Therapy with alloantigen-specific CD4CD25 T regulatory cells (Treg) for induction of transplant tolerance is desirable, as naïve thymic Treg (tTreg) are not alloantigen-specific and are weak suppressor cells. Naïve tTreg from DA rats cultured with fully allogeneic PVG stimulator cells in the presence of rIL-2 express IFN-gamma receptor (IFNGR) and IL-12 receptor beta2 (IL-12Rβ2) and are more potent alloantigen-specific regulators that we call Ts1 cells. This study examined additional markers that could identify the activated alloantigen-specific Treg as a subpopulation within the CD4CD25Foxp3Treg. After culture of naïve DA CD4CD8CD25T cells with rIL-2 and PVG alloantigen, or rIL-2 without alloantigen, CD8α was expressed on 10-20% and CD8β on <5% of these cells. These cells expressed and . CD8α cells had increased that characterizes Ts1 cells as well was , a transcription factor induced by TCR activation. Proliferation induced by re-culture with rIL-12 and alloantigen was greater with CD4CD8αCD25Treg consistent with the CD8α cells expressing IL-12R. In MLC, the CD8α fraction suppressed responses against allogeneic stimulators more than the mixed Ts1 population, whereas the CD4CD8CD25T cells were less potent. In an adoptive transfer assay, rIL-2 and alloantigen activated Treg suppress rejection at a ratio of 1:10 with naïve effector cells, whereas alloantigen and rIL-2 activated tTreg depleted of the CD8α cells were much less effective. This study demonstrated that expression of CD8α by rIL-2 and alloantigen activation of CD4CD8CD25Foxp3T cells was a marker of activated and potent Treg that included alloantigen-specific Treg.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802415 | PMC |
http://dx.doi.org/10.3389/fimmu.2019.02397 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!